A lipid lover's guide to novel therapeutics for lipid and cardiovascular risk reduction.

摘要: Lipids and lipoproteins are the target of many novel therapeutics an area with great potential for prevention treatment cardiovascular disease (CVD). Reduction low-density lipoprotein cholesterol has been mainstay reducing burden CVD, however, several other atherogenic particles have more recently come into spotlight as avenues primary and/or secondary CVD. These include triglycerides, high sensitivity C-reactive protein, apolipoprotein A, C3 lipoprotein(a). In this review, we showcase to lipid risk reduction that either in development or approved use. We discuss mechanisms action, data from clinical trials expected effects each therapy based on current body literature.